Term
|
Definition
| Estradiol (most common), Ethinyl Estradiol, Mestranol, Estradiol valerate, Conjugated Estrogens |
|
|
Term
|
Definition
| Norgestimate, etonogesterel, levonorgesterel, medroxyprogesterone, norelgestromin, drospirenone, desogesterel, gestodoene, ulipristal, norethindrone |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Sermorellin acetate (Geref) |
|
|
Term
|
Definition
| somatomedin C (mescasermin, increlex) |
|
|
Term
|
Definition
| octreotide, lanreatide, vapreotide |
|
|
Term
|
Definition
| bromocriptine and cabergoline |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| Competitive, nonspecific estrogen receptor antagonist |
|
Definition
| Clominphene citrate (Clomid) |
|
|
Term
|
Definition
| rhFSH- medtrodin or Urofollitropin |
|
|
Term
| human menopausal gonadotropin (LSH or LH activities) |
|
Definition
|
|
Term
|
Definition
| Human chorionic gonadotropin (rhCG) |
|
|
Term
| ADH analog replaced by increased expression of AQP2: |
|
Definition
| Vasopressin and Desmopressin |
|
|
Term
| Antagonizes action of ADH through an unknown post receptor mechanism |
|
Definition
|
|
Term
|
Definition
| conivaptan, tolvaptin, lixivaptan |
|
|
Term
| Inhibitor of 11 B-hydroxylase |
|
Definition
|
|
Term
|
Definition
| Aminoglutethimide (Cytadren) |
|
|
Term
| at appropriate doses preferentially inhibits 17 alpha hydroxylation and inhibits formulation and adrenal androgens |
|
Definition
|
|
Term
| cytotoxic agent that acts on normal and neoplastic adrenocorticol cells |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Propylthiouracil (PTU); Methimazole (Tapazole) |
|
|
Term
| Type 2-5 alpha reductase inhibitors |
|
Definition
| Finasteride (proscar) and Dutasteride (Avodart) |
|
|
Term
| Long Acting Alpha 1 adrenergic receptor antagonists |
|
Definition
| Terazosin, doxazosin, tamsulosin, alfuzosin |
|
|
Term
|
Definition
|
|
Term
| autologous cellular immunotherapy for treatment of symptomatic/minimally symptomatic prostate cancer, which isn't responsive to testosterone deprivation |
|
Definition
|
|
Term
| Androgen receptor antagonists |
|
Definition
|
|
Term
| Central acting CNS drugs that alter adrenergic, dopaminergic and/or serotonergic receptor activities regulating male sexual fxn |
|
Definition
| Anti-depressants, Anti-psychotics, Anxiolytics |
|
|
Term
|
Definition
| Sidenafil citrate, vardenafil, Tadafil |
|
|
Term
| transurethral suppository long acting drug that leads to the relaxation of arterial and trabercular smooth muscle |
|
Definition
|
|
Term
| Alpha Glucosidase INhibitors |
|
Definition
|
|
Term
|
Definition
|
|
Term
| Insulin (onset 15-20 min) |
|
Definition
|
|
Term
|
Definition
| Humalin regular, Novolin regular |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| Protein that acts on hypothalamus to decrease appetite |
|
Definition
|
|
Term
| Promotes fatty acid oxidation in muscles and suppresses hepatic glucose release |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Rosiglitazone and Pioglitazone |
|
|
Term
|
Definition
|
|
Term
| Sulfonylureas 1st generation |
|
Definition
| Acetohexamide, Tolbutamide |
|
|
Term
| Sulonylureas 2nd generation |
|
Definition
| Glipizde, Glyburide, Glimepiride |
|
|
Term
|
Definition
|
|
Term
| glucagon like peptide-1 (GLP-1) |
|
Definition
|
|
Term
| dipeptidyl peptidase IV inhibitors (DDP-4) |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Ibandronate or Zoledronate |
|
|
Term
| peptide sequence that antagonizes the effects of PTH |
|
Definition
|
|
Term
| Antagonizes GI absorption |
|
Definition
| High dose glucocorticoids |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Calcium carbonate (40%), Calcium gluconate (9%), Calcium Citrates of Citracal (21%), Calcium Lactage (13%) |
|
|
Term
|
Definition
|
|
Term
| Selective Estrogen receptor modulators (SERMs) |
|
Definition
|
|
Term
|
Definition
|
|
